482 related articles for article (PubMed ID: 27343545)
1. Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis.
Low AJ; Mburu G; Welton NJ; May MT; Davies CF; French C; Turner KM; Looker KJ; Christensen H; McLean S; Rhodes T; Platt L; Hickman M; Guise A; Vickerman P
Clin Infect Dis; 2016 Oct; 63(8):1094-1104. PubMed ID: 27343545
[TBL] [Abstract][Full Text] [Related]
2. Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs.
Mukandavire C; Low A; Mburu G; Trickey A; May MT; Davies CF; French CE; Looker KJ; Rhodes T; Platt L; Guise A; Hickman M; Vickerman P
AIDS; 2017 May; 31(8):1181-1190. PubMed ID: 28323752
[TBL] [Abstract][Full Text] [Related]
3. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
Miller WC; Hoffman IF; Hanscom BS; Ha TV; Dumchev K; Djoerban Z; Rose SM; Latkin CA; Metzger DS; Lancaster KE; Go VF; Dvoriak S; Mollan KR; Reifeis SA; Piwowar-Manning EM; Richardson P; Hudgens MG; Hamilton EL; Sugarman J; Eshleman SH; Susami H; Chu VA; Djauzi S; Kiriazova T; Bui DD; Strathdee SA; Burns DN
Lancet; 2018 Sep; 392(10149):747-759. PubMed ID: 30191830
[TBL] [Abstract][Full Text] [Related]
4. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.
Larney S; Peacock A; Leung J; Colledge S; Hickman M; Vickerman P; Grebely J; Dumchev KV; Griffiths P; Hines L; Cunningham EB; Mattick RP; Lynskey M; Marsden J; Strang J; Degenhardt L
Lancet Glob Health; 2017 Dec; 5(12):e1208-e1220. PubMed ID: 29074410
[TBL] [Abstract][Full Text] [Related]
5. Alcohol Use and Antiretroviral Therapy Non-Adherence Among Adults Living with HIV/AIDS in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
Velloza J; Kemp CG; Aunon FM; Ramaiya MK; Creegan E; Simoni JM
AIDS Behav; 2020 Jun; 24(6):1727-1742. PubMed ID: 31673913
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs.
Nosyk B; Min JE; Evans E; Li L; Liu L; Lima VD; Wood E; Montaner JS
Clin Infect Dis; 2015 Oct; 61(7):1157-65. PubMed ID: 26113656
[TBL] [Abstract][Full Text] [Related]
7. Mortality and virological failure among HIV-infected people who inject drugs on antiretroviral treatment in China: An observational cohort study.
Zhao Y; Zhang M; Shi CX; Huang J; Zhang F; Rou K; Wu Z
Drug Alcohol Depend; 2017 Jan; 170():189-197. PubMed ID: 27987476
[TBL] [Abstract][Full Text] [Related]
8. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
Degenhardt L; Mathers BM; Wirtz AL; Wolfe D; Kamarulzaman A; Carrieri MP; Strathdee SA; Malinowska-Sempruch K; Kazatchkine M; Beyrer C
Int J Drug Policy; 2014 Jan; 25(1):53-60. PubMed ID: 24113623
[TBL] [Abstract][Full Text] [Related]
9. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
Mathers BM; Degenhardt L; Ali H; Wiessing L; Hickman M; Mattick RP; Myers B; Ambekar A; Strathdee SA;
Lancet; 2010 Mar; 375(9719):1014-28. PubMed ID: 20189638
[TBL] [Abstract][Full Text] [Related]
10. "They don't like us….": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study.
Kumar S; Gupte HA; Isaakidis P; Mishra JK; Munjattu JF
PLoS One; 2018; 13(8):e0203262. PubMed ID: 30161255
[TBL] [Abstract][Full Text] [Related]
11. Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization.
Suthar AB; Rutherford GW; Horvath T; Doherty MC; Negussie EK
AIDS; 2014 Mar; 28 Suppl 2():S175-85. PubMed ID: 24849478
[TBL] [Abstract][Full Text] [Related]
12. The causal effect of opioid substitution treatment on HAART medication refill adherence.
Nosyk B; Min JE; Colley G; Lima VD; Yip B; Milloy MJ; Wood E; Montaner JS
AIDS; 2015 May; 29(8):965-73. PubMed ID: 25915170
[TBL] [Abstract][Full Text] [Related]
13. High rates of police detention among recently released HIV-infected prisoners in Ukraine: implications for health outcomes.
Izenberg JM; Bachireddy C; Soule M; Kiriazova T; Dvoryak S; Altice FL
Drug Alcohol Depend; 2013 Nov; 133(1):154-60. PubMed ID: 23769160
[TBL] [Abstract][Full Text] [Related]
14. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
Spire B; Lucas GM; Carrieri MP
Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
[TBL] [Abstract][Full Text] [Related]
15. HIV care continuum characteristics among people with opioid use disorder and HIV in Vietnam: baseline results from the BRAVO study.
King C; Giang LM; Bart G; Kunkel L; Korthuis PT
BMC Public Health; 2020 Mar; 20(1):421. PubMed ID: 32228522
[TBL] [Abstract][Full Text] [Related]
16. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
Roux P; Carrieri MP; Cohen J; Ravaux I; Poizot-Martin I; Dellamonica P; Spire B
Clin Infect Dis; 2009 Nov; 49(9):1433-40. PubMed ID: 19807275
[TBL] [Abstract][Full Text] [Related]
17. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
[TBL] [Abstract][Full Text] [Related]
18. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
[TBL] [Abstract][Full Text] [Related]
19. HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy.
J Minhas H; Akiyama MJ; Norton BL; Heo M; Arnsten JH; Litwin AH
AIDS Care; 2022 Oct; 34(10):1229-1233. PubMed ID: 34533062
[TBL] [Abstract][Full Text] [Related]
20. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
